Champions Oncology, Inc.(CSBR)

Champions Oncology grew revenue 8.8% to $15.2 million while cost of revenue actually fell, lifting gross margin 7.6 points to 50.5% — but the entire $1.7 million gross profit gain was consumed by a 67% jump in sales and marketing spend and stock compensation at its new Corellia subsidiary, leaving the operating loss barely changed and cash down to $4.4 million.